You can go back to the JPMorgan healthcare presentation available on the Myriadphara.com website.
As I recall, when they discussed this, MYRX said the FDA had the 60 days to determine the status. They also pinpointed the 12/2/10 date as the latest date for final determination, at which time they would need a hospital sales staff to implement the use of Dyloject. In the presentation they said IF priority status is granted, final determination would be six months earlier. That would be 6/2/10.
I do not recall if they actually noted the date of application. Let me know if you have that information, as I just assumed it was 12/2/09 given the timeline they discussed.
Yeah, everything is great with this merger as both stocks continue to get hammered. JAV is garbage, get it through your thick head idiot. We will back out and leave you with nothing, you don;t even know if the NDA will be accepted and you are already talking about priority review, idiot.